本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Travere Therapeutics, Inc.

21.64
+0.49002.32%
盤前21.650.0100+0.05%07:00 EDT
成交量:391.29萬
成交額:8,489.28萬
市值:19.29億
市盈率:-10.82
高:22.24
開:21.36
低:21.19
收:21.15
52周最高:25.29
52周最低:10.64
股本:8,913.87萬
流通股本:7,928.57萬
量比:1.39
換手率:4.94%
股息:- -
股息率:- -
每股收益(TTM):-1.9993
每股收益(LYR):-4.0759
淨資產收益率:-705.73%
總資產收益率:-19.28%
市淨率:58.90
市盈率(LYR):-5.31

資料載入中...

2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

重要事件披露

Form 8-K - Current report
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans